Cellectar Biosciences (CLRB) Preferred Stock Liabilities (2021 - 2025)
Cellectar Biosciences (CLRB) recorded Preferred Stock Liabilities of $2.76 million in Q4 2025, up 100.0% from $1.38 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Preferred Stock Liabilities (2021 - 2025) Analysis & Trends
Starting with Q4 2021, Cellectar Biosciences' Preferred Stock Liabilities history includes 17 quarters.
- Annual Preferred Stock Liabilities has a four-year compound annual growth rate of 18.9% (FY2021 to FY2025).
- Across earlier years, Preferred Stock Liabilities came in at $1.38 million in FY2024 (unchanged), $1.38 million in FY2023 (unchanged), $1.38 million in FY2022 (unchanged) and $1.38 million in FY2021.
- Quarterly Preferred Stock Liabilities has ranged from $1.38 million in Q4 2021 to $19.2 million in Q3 2023 over the past five years.
- On a year-over-year basis, Preferred Stock Liabilities rose in two of the last eight quarters, with growth averaging 13.4%.
- Peak year-over-year performance for Preferred Stock Liabilities in the last five years was growth of 100.0% in Q4 2025, against a decline of 92.8% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.76 million (Q3 2025), $1.38 million (Q2 2025) and $1.38 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Cellectar Biosciences | 22.51 Mn | 22.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 19.20 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 2.76 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 1.38 Mn |
API Access
Cellectar Biosciences Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();